Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Mycosis fungoides and the Sezary syndrome (SS) are rare lymphomas of CD4+ helper T cells. There is stagewise progression from patch/plaques to thicker tumor lesions/diffuse erythroderma. Blood involvement is a characteristic of SS. Outcomes are related to the extent of skin, blood, lymph node, and visceral organ involvement. Patients with limited patch and plaque disease are treated with skin-directed therapies. More advanced/refractory disease is treated with skin-directed therapies and oral or systemic immunomodulatory agents. Single-agent chemotherapies are used against tumors, refractory plaques, and lymph node and visceral involvement. Allogeneic stem cell transplantation is a potentially curative strategy for advanced/resistant disease. Copyright © 2016 Elsevier Inc. All rights reserved.

Citation

Francine M Foss, Michael Girardi. Mycosis Fungoides and Sezary Syndrome. Hematology/oncology clinics of North America. 2017 Apr;31(2):297-315

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 28340880

View Full Text